Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Transfection, Cell Lines and Primary Cancer Cells
Authors:
Freund EC, Lock JY, Oh J, Maculins T, Delamarre L, Bohlen CJ, Haley B, Murthy A.
In:
J Exp Med (2020) 217(7): e20191692
Categories:
Transfection
Authors:
Gade P, Roy SK, Li H, Nallar SC, Kalvakolanu DV
In:
Mol Cell Biol (2008) 28(8): 2528-48
Categories:
Transfection
Authors:
Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R
In:
Nat Immunol (2008) 9(4): 361-8
Categories:
Transfection
Authors:
Wang Z, Liu B, Wang P, Dong X, Fernandez-Hernando C, Li Z, Hla T, Li Z, Claffey K, Smith JD, Wu D
In:
J Clin Invest (2008) 118(1): 195-204
Categories:
Transfection
Authors:
Zhang TY, Daynes RA
In:
J Immunol (2007) 179(9): 6325-35
Categories:
Transfection
Authors:
De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J
In:
EMBO J (2007) 26(12): 2823-31
Categories:
Transfection
Authors:
Zhang TY, Daynes RA
In:
J Immunol (2007) 178(4): 2517-26
Categories:
Transfection
Authors:
Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, Hisaeda H, Yamamoto M, Akira S, Himeno K, Matsumoto M, Takeda K
In:
J Immunol (2006) 177(10): 7059-66
Categories:
Transfection
Authors:
Mauldin JP, Srinivasan S, Mulya A, Gebre A, Parks JS, Daugherty A, Hedrick CC
In:
J Biol Chem (2006) 281(30): 21216-24
Categories:
Transfection
Authors:
Kagan JC, Medzhitov R
In:
Cell (2006) 125(5): 943-55
+ Show All